<div id="readability-page-1"><div><p>Fujian Wanchen Biotechnology Group Co.,Ltd. reported earnings results for the nine months ended September 30, 2025. For the nine months, the company reported sales was CNY 36,562.31 million compared to CNY 20,613.1 million a year ago. Net income was CNY 854.98 million compared to CNY 84.07 million a year ago.</p><p>Basic earnings per share from continuing operations was CNY 4.684 compared to CNY 0.5001 a year ago. Diluted earnings per share from continuing operations was CNY 4.3431 compared to CNY 0.4647 a year ago.</p></div></div>

万辰集团

<p>福建万辰生物科技集团有限公司公布了截至 2025 年 9 月 30 日的九个月财报。该公司在这九个月内的销售额为 365.6231 亿元人民币，而去年同期为 206.131 亿元人民币。净收入为 8.5498 亿元人民币，而去年同期为 8407 万元人民币。来自持续经营的基本每股收益为 4.684 元人民币，而去年同期为 0.5001 元人民币。来自持续经营的摊薄每股收益为 4.3431 元人民币，而去年同期为 0.4647 元人民币</p>

福建万辰生物科技集团有限公司公布了截至2025年9月30日的九个月财务业绩